Skip to main content
Premium Trial:

Request an Annual Quote

Komen Foundation, American Airlines to Raise $8M for Breast Cancer 'Omics

NEW YORK (GenomeWeb News) – Susan G. Komen for the Cure, a non-profit breast cancer research advocacy organization, has teamed with American Airlines to raise $8 million to support a project at the University of Texas’ MD Anderson Cancer Center that will use genomics, proteomics, and nanotechnology to study and treat inflammatory breast cancer.
Under the terms of the agreement, American will raise $7.5 million for Komen's first Promise Grant, which will support the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic for eight years.
The focus of the research will be to discover ways to diagnose IBC earlier and to develop treatments tailored to the disease.
IBC is a rare but aggressive form of breast cancer that is not detectable by mammography or ultrasound, and which is “often resistant to existing breast cancer treatments,” Komen for the Cure said.
Komen said it started the Promise Grants program to get researchers to collaborate in new ways to develop breast cancer diagnostic tools and treatments.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.